Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Two Formulations of GSK's DTPa-HBV-IPV/Hib Vaccine in Healthy Infants
NCT00320463Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pertussis filamentous haemagglutinin in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by GSK. Started Apr 2006; status: completed.
02
Drugs
pertussis filamentous haemagglutinin
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT00320463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320463.